Two versus three doses of Menjugate in infants from Germany.
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2011
At a glance
- Drugs Hib-DTaP-hepatitis B-poliovirus vaccine; Meningococcal vaccine group C conjugate; Meningococcal vaccine groups A and C polysaccharide
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group C infections; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Chiron Behring
- 27 Jun 2011 New source for the extension trial identified and integrated (European Clinical Trials Database record EudraCT2004-005150-31).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History